Vor Biopharma
VOR
VOR
54 hedge funds and large institutions have $33.5M invested in Vor Biopharma in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 20
65% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 26
Holders
54
Holding in Top 10
1
Calls
$13K
Puts
–
Top Buyers
| 1 | +$1.73M | |
| 2 | +$854K | |
| 3 | +$182K | |
| 4 |
Two Sigma Investments
New York
|
+$96K |
| 5 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$53.7K |
Top Sellers
| 1 | -$6.46M | |
| 2 | -$1.75M | |
| 3 | -$247K | |
| 4 |
Goldman Sachs
New York
|
-$243K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$187K |